Pasithea Therapeutics (KTTAW) Stock Chart & Stock Price History $0.02 0.00 (-11.57%) As of 06/20/2025 09:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Pasithea Therapeutics Stock Price Performance The Pasithea Therapeutics (KTTAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 12.35%, with a year-to-date return of -44.80%. In the past month, the stock has decreased 10.33%, reflecting recent market activity. As of the latest close, Pasithea Therapeutics traded at $0.02 with a market cap of and volume of 732 shares. Receive KTTAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.24%1 Month Performance-10.33%3 Month Performance-4.50%Year-To-Date Performance-44.80%1 Year Performance+12.35% KTTAW Stock Chart for Sunday, June, 22, 2025 KTTAW Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$0.02$0.02$0.02$0.02732 shs$0.0006/19/2025$0.02$0.02$0.02$0.02100 shs$0.0006/18/2025$0.02$0.02+3.24%$0.02$0.02100 shs$0.0006/17/2025$0.02$0.02+3.35%$0.02$0.02392 shs$0.0006/16/2025$0.02$0.02+12.58%$0.02$0.027,200 shs$0.0006/13/2025$0.02$0.02-20.10%$0.02$0.027,205 shs$0.0006/12/2025$0.02$0.02+22.09%$0.02$0.02400 shs$0.0006/11/2025$0.02$0.02$0.02$0.02800 shs$0.0006/10/2025$0.02$0.02-18.50%$0.02$0.02850 shs$0.0006/09/2025$0.02$0.02$0.02$0.021,000 shs$0.00 Get the Latest News and Ratings for KTTAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$0.02$0.02$0.02$0.021,000 shs$0.0006/05/2025$0.02$0.02$0.02$0.021,000 shs$0.0006/04/2025$0.02$0.02$0.02$0.021,000 shs$0.0006/03/2025$0.02$0.02-14.75%$0.02$0.021,000 shs$0.0006/02/2025$0.02$0.02+35.63%$0.02$0.021,000 shs$0.0005/30/2025$0.02$0.02-26.27%$0.02$0.023,700 shs$0.0005/29/2025$0.02$0.02$0.02$0.023,700 shs$0.0005/28/2025$0.02$0.02$0.02$0.023,700 shs$0.0005/27/2025$0.02$0.02$0.02$0.023,700 shs$0.0005/23/2025$0.02$0.02$0.02$0.023,700 shs$0.0005/22/2025$0.01$0.02+58.96%$0.02$0.023,700 shs$0.0005/21/2025$0.02$0.01-27.57%$0.02$0.023,700 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Calithera Biosciences Stock Price Chart Receive KTTAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTAW) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KTTAW Stock Free KTTAW Stock Alerts